Oncogene:Plectin是前列腺癌生长和转移的调节因子

2020-12-07 AlexYang MedSci原创

前列腺癌每年造成3万多美国人死亡,主要归因于无法治愈的转移性疾病。

前列腺癌每年造成3万多美国人死亡,主要归因于无法治愈的转移性疾病。

最近,有研究人员阐释了与良性前列腺组织相比,高水平的plectin与局部和转移性人类前列腺癌有关。敲除plectin能够抑制前列腺癌细胞在体外的生长和克隆形成,以及体内前列腺癌异种移植的生长。Plectin敲除能够进一步干扰通过体外迁移、入侵和伤口愈合评估的侵袭性和侵入性细胞行为。一致地,plectin基因敲除细胞的远处部位转移定植受损,包括肝、肺、肾、骨和泌尿生殖系统。Plectin基因敲除抑制了每个器官的转移数量,并降低了整体转移负担。为了深入了解plectin在前列腺癌生长和转移中的作用,研究人员对前列腺癌plectin敲除异种移植组织进行了蛋白质组学分析。基因集富集分析表明,与细胞外基质和层粘连蛋白相互作用有关的蛋白质水平增加,而调节氨基酸代谢、细胞骨架蛋白和细胞应激反应蛋白质水平下降。

Plectin敲除能够抑制前列腺癌细胞的生长

最后,研究人员指出,他们的研究发现阐释了plectin是前列腺癌细胞生长和转移的重要调节因子。

原始出处:

Mark Buckup, Meghan A. Rice, En-Chi Hsu et al. Plectin is a regulator of prostate cancer growth and metastasis. Oncogene. Nov 2020

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2049348, encodeId=823020493481e, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Apr 11 23:24:45 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969276, encodeId=d2d119692e6f5, content=<a href='/topic/show?id=10e09205572' target=_blank style='color:#2F92EE;'>#调节因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92055, encryptionId=10e09205572, topicName=调节因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Sep 10 00:24:45 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558207, encodeId=6e14155820e7f, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Wed Dec 09 05:24:45 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040902, encodeId=9fbc10409024f, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 07 17:24:45 CST 2020, time=2020-12-07, status=1, ipAttribution=)]
    2021-04-11 cy0324
  2. [GetPortalCommentsPageByObjectIdResponse(id=2049348, encodeId=823020493481e, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Apr 11 23:24:45 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969276, encodeId=d2d119692e6f5, content=<a href='/topic/show?id=10e09205572' target=_blank style='color:#2F92EE;'>#调节因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92055, encryptionId=10e09205572, topicName=调节因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Sep 10 00:24:45 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558207, encodeId=6e14155820e7f, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Wed Dec 09 05:24:45 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040902, encodeId=9fbc10409024f, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 07 17:24:45 CST 2020, time=2020-12-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2049348, encodeId=823020493481e, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Apr 11 23:24:45 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969276, encodeId=d2d119692e6f5, content=<a href='/topic/show?id=10e09205572' target=_blank style='color:#2F92EE;'>#调节因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92055, encryptionId=10e09205572, topicName=调节因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Sep 10 00:24:45 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558207, encodeId=6e14155820e7f, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Wed Dec 09 05:24:45 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040902, encodeId=9fbc10409024f, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 07 17:24:45 CST 2020, time=2020-12-07, status=1, ipAttribution=)]
    2020-12-09 zsyan
  4. [GetPortalCommentsPageByObjectIdResponse(id=2049348, encodeId=823020493481e, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Apr 11 23:24:45 CST 2021, time=2021-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969276, encodeId=d2d119692e6f5, content=<a href='/topic/show?id=10e09205572' target=_blank style='color:#2F92EE;'>#调节因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92055, encryptionId=10e09205572, topicName=调节因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Sep 10 00:24:45 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558207, encodeId=6e14155820e7f, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Wed Dec 09 05:24:45 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040902, encodeId=9fbc10409024f, content=前列腺癌相关研究,学习了,谢谢梅斯, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 07 17:24:45 CST 2020, time=2020-12-07, status=1, ipAttribution=)]
    2020-12-07 misszhang

    前列腺癌相关研究,学习了,谢谢梅斯

    0

相关资讯

Nat Cell Biol: 癌细胞“成瘾”背后的化学反应

研究表明,SLC7A11基因水平高的癌症可能对葡萄糖转运蛋白抑制剂的治疗有反应。

Sci Adv:癌细胞为了转移长出“手指”!高侵袭性肺癌前导细胞“手指”更长

肿瘤的异质性是恶性肿瘤的特征之一,是指肿瘤在生长过程中,经过多次分裂增殖,其子细胞呈现出分子生物学或基因方面的改变,从而使肿瘤的生长速度、侵袭能力、对药物的敏感性、预后等各方面产生差异。

Nature:一种单一的设计性DNA药物治疗有望完全治愈帕金森症!

虽然大多数治疗策略旨在防止神经元丢失或保护脆弱的神经元回路,但近日,付向东团队成功替换丢失的神经元以重建中断的回路,完全治愈了小鼠的帕金森病。

Oncogene:长非编码RNA PENG能够抑制透明细胞肾细胞癌的细胞增殖

PDZK1下调能够独立的预测透明细胞肾细胞癌(ccRCC)患者的不良预后并诱导ccRCC的发展和恶化。然而,PDZK1下调潜在的机制仍旧不清楚。竞争性内源RNA(ceRNA)网络在基因调控中扮演着新的

Nat. Rev Neurosci:对435563人酒精使用问题进行全基因组meta分析,深入了解生物学以及与其他性状的关系

酗酒是世界范围内导致死亡和残疾的主要原因。虽然全基因组关联研究已经确定了PAU的危险基因,但这一特性的遗传结构尚未完全了解。

J Hepatology: β-Klotho基因变异与NAFLD儿童肝损害有关

非酒精性脂肪肝疾病(NAFLD)是成人和儿童慢性肝病的主要原因。除肥胖症,糖尿病和胰岛素抵抗外,遗传因素也对NAFLD的发生和发展产生强烈影响。胆汁酸代谢失调和成纤维细胞生长因子19(FG